MS (Multiple Sclerosis)

For a drug that’s based on rat antibodies, it’s not surprising that doctors are already starting to report life-threatening side effects in patients taking the new multiple sclerosis (MS) drug Lemtrada (alemtuzumab). Inflammation in their brains Two MS patients started to decline rapidly after they were given Lemtrada, and MRI scans revealed that a new form of inflammation had affected ...

Read More »